The day I was diagnosed was the scariest day of my life.
Do I Get
The Test?
A breast cancer diagnosis shakes you to the core. It also means you’re suddenly faced with a million decisions.
Breast Cancer Index® will help bring clarity to you and your oncology team as you approach the five-year point after your initial diagnosis and consider your duration of anti-estrogen therapy.
Not Another Minute Not Knowing If Treatment is Benefiting You
You can’t take the fear out of cancer.
But you can reduce the
uncertainty around treating it.
Breast Cancer Index Is Changing
The Game.
If you have early-stage hormone receptor–positive (HR+) breast cancer and you and your oncologist are weighing treatment options — Breast Cancer Index will give you and your care team information you need to make the right treatment decision for you.
The Test Will Give You Information To Help You Answer These Questions:
- Am I Likely To Benefit From Extended Anti-Estrogen Therapy?
- What Is My Risk Of Late-Distant Recurrence?
This test can be an important tool in helping you and your oncology team determine whether extending anti-estrogen therapy past 5 years may be beneficial for you.
The test is performed only by Biotheranostics, Inc.
Your Breast Cancer Timeline
If you’ve been diagnosed with breast cancer, it may be hard to think beyond the minute you’re in. But the results of your Breast Cancer Index test can help give you and your oncology team more certainty as you develop your treatment plan.
Diagnosis is The First Step
The first point on the timeline for cancer treatment is what doctors refer to as “Time Zero.” For patients, this can be a world-shattering time full of chaos and information overload.
You Are Here
You’ve recently been diagnosed with early-stage, HR+ breast cancer. Your doctor has told you that taking anti-estrogen therapy for at least 5 years can help reduce your risk of the cancer returning, but it is unclear whether longer treatment could also be beneficial.
Nearly 95% of Women Do Not Benefit from Anti-Estrogen Therapy After 5 Years1-6
While most women with early-stage, HR+ breast cancer are prescribed anti-estrogen therapy, the duration of treatment may vary from patient to patient — at least 5 years of anti-estrogen therapy is usually recommended to help prevent a recurrence of your cancer.12
Breast Cancer Index can help you and your doctor determine whether a longer course of treatment is likely to benefit you.
Talk to your doctor about Breast Cancer Index to understand when the test may be right for you.
Know If Additional Treatment is Right For You
For some women, extending anti-estrogen therapy through year 10 may reduce the risk of recurrence.
Breast Cancer Index can help you and your doctor decide what is right for you.
